chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He had seizures.  He was admitted to the hospital.  He was seen in the emergency room first.  5/23/08 Reviewed hospital medical records of 4/28/2008. FINAL DX: no d/c summary as was less that 24 hr admit.  Admit dx: possible seizures.  Neuro consult states new onset seizures likely dx. Records reveal patient experienced bilateral high frequency shaking movements of arms, legs stiff, eyes staring lasting approx 30-40 secs then was irritable before returning to baseline. Episode was repeated x 2 & taken to ER.  Transferred to higher level of care.  LP done, labs repeated & tx w/antibiotics.  Neuro consult done.  Was being treated for bacterial conjunctivitis on day of vaccination.  No further seizure like activity observed while hospitalized.  D/c to home on no meds.
3 days after vaccine I got whelps on left rear of neck.  I took benadryl.  numbness started moving to side of jaw and toward my throat.  I took another benadryl w/i 30 mins of 1st benadryl.  I continued benadryl every 2 hrs til around 11pm.  worst symptoms had subsided before going to bed.  4th day I still had a few wheps on back of neck and was taking benadryl twice daily.  symptoms were gone by 5th day.
Skin sensitivity; mild pain on all areas of the skin; Skin sensitivity/mild pain on all areas of the skin, not just at injection site; This is a spontaneous report from a contactable consumer (patient). A 44-years-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number and expiration date was not reported), via an unspecified route of administration, administered in left arm on 19Feb2021 15:00 (at the age of 44-years-old) as single dose for covid-19 immunization. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) on 29Jan2021 (discrepant information: also reported as 29Feb2021). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included moderately high blood pressure and drug allergy to penicillin. Concomitant medication included cholecalciferol (vitamin D). On 20Feb2021 09:00, the patient experienced skin sensitivity/mild pain on all areas of the skin, not just at injection site. (For example, mild pain when rolling up sleeves to wash hands. The patient did not receive any treatment. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
ACID) for Product for unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, BONE PAIN (Pain in the bones), PAIN (Body ache), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Information has been received from a registered nurse concerning a male patient of unknown age. The patient's concurrent conditions, medical histories and concomitant therapies were not reported. On 17-JAN-2017 (also reported as 4 days ago), the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose and route were unknown), for prophylaxis. On an unknown date in January 2017, the patient experienced redness and itching at injection site. There are no vesicles being reported. No treatment had been employed. The outcome of the events was unknown. The reporter did not assess the causality. Additional information is not expected as the reporter did not want to be contacted.
pt recvd vax 2FEB95 & 13FEB was having trouble sleeping; on the 14FEB gave pt tiny piece of chocolate-pt broke out w/red tiny dots all over;
fever, low blood pressure, high heart rate, anemia, fluid on lungs.  hospitalized 2/19-2/23, 2/26-3/1, and 3/15-current
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On an unknown date in 2014 (reported as "about a year ago"), the patient was vaccinated with an unknown dose of ZOSTAVAX (route, lot# and expiry date were not reported). Then, on 04-OCT-2015, the patient was vaccinated with the second dose of ZOSTAVAX (lot # L016284, expiry date 07-AUG-2016; dose and route were not reported). No adverse experiences were reported. Additional information has been requested.
Loss of pigmentation where the ID vaccine was given. Noticed 4 weeks after shot was given.
Bell's Palsy of right face, diagnosed in ER with treatment of prednisone and valacyclovir
Covid 19 vaccine use for COVID-19 under Emergency Use Authorization (EUA): Development of tetanus after recieving covid 19 vaccine
gave me shingles/felt like a stick in my eye; allergic to the shot; scratching and inching my forehead; scar tissue behind my eye; gave me shingles; This case was reported by a consumer via media and described the occurrence of ophthalmic herpes zoster in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), allergy, pruritus, scar and shingles. On an unknown date, the outcome of the ophthalmic herpes zoster, allergy, pruritus, scar and shingles were unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster, allergy, pruritus, scar and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient reported the case for herself/himself. The age at vaccination was not reported. The patient received Shingles shot and experienced shingles it felt like a stick in her/his eye it was awful and allergic to the shot and there's no way patient was having a second dose.  Two years later patient still scratching and inching her/his forehead and now have scar tissue behind her/his eye from it. The follow up would not be possible as no contact details were available.
By 6:00pm on the day of my second dose, i began experiencing a severe headache, chills and muscle aches. My temperature got as high as 102.7 that evening and through the night. These symptoms persisted throughout the day following my vaccine. It finally started to improve on the second day after the vaccine. The severity of symptoms lessened throughout that second day and I felt better by 8PM on 2-12-2021.
Lower back pain; This is a spontaneous report from a contactable physician reported that a 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 25Apr2021 (at the age of 44-years-old) as 2nd dose, single for covid-19 immunization. The patient has a significant medical history which included that she has problems with her immune system. The patient has an immune system disorder that when she was two years old, she had to be put in a bubble to isolate and to protect her from pathogens. The patient said that her heart stopped beating at that time. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported) on an unspecified date as 1st dose for covid-19 immunisation. The patient's concomitant medications were not reported. After the second dose, the patient experienced lower back pain on 26Apr2021. The event resulted in two ER visits, two days apart, and physician office visit as the patient saw her primary care physician today (12May2021). The event was considered as medically significant. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event lower back pain cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
pt recv vax 3FEB97 & 2 days later it was reported that pt exp crushing & extreme tightness in chest;forceful cough, producing blood which lasted throughout the noc;
One day after being vaccinated, dull headache (anticipated that) but got a progressively worse pain in my left hip (only).  I've never had hip pain.  Standing was fine.  Getting up from a sitting position was excruciating.  Difficulty getting into my Jeep (could not raise left leg), and excruciating pain getting out of the Jeep.  Could not bend to pick up anything, could not put on socks, painful rolling over in bed.  This lasted 3 full days.  It got a little better each day after that.  Today (3 weeks later) my hip is 95% back to normal.  I had not done any heavy lifting, etc. to have caused an injury to my hip.  No other joint pain whatsoever.  Just left hip affected.
Pt was administered two shots at same time. During Pneumovax  injection a needle malfunction happened in which the medication was not able to be ejected.  New needle was applied and then administered with no issues.  Pt said she then went shopping for approximately 45 minutes.  Upon returning home began to unpack groceries at which time her arm became extremely sore from her "collarbone to the palms of her hand" of the arm she got the vaccines in.  Swelling and bruising have occurred at injection site.  Pt stated that she had a mild fever, maxing out at 100.1F.  Pain was self described as an 8 out of 10.  Arm was still bruised and swollen on 6/8/20.
Noticed on Thursday (10/8) arm was warm. Came to pharmacy 10/13 with red arm. About 2" around shot. Feels warm. Was itchy Sunday 10/11.
Body ache (muscle, headache, stomachache), fatigue, tiredness, nausea
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about late 2017, for routine health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. On an unspecified date shortly after receiving ZOSTAVAX, the patient developed a painful rash, headaches, nausea, dizziness, and balance issues. The patient then began to experience a loss in vision in one eye and a significant decrease in vision in the other. In response to these complaints, on an unknown date, the patient presented to his primary care physician and specialists, and was ultimately diagnosed with postherpetic neuralgia and macular degeneration. The outcome of the events is unknown. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, macular degeneration was determined to be medically significant. Additional information has been requested.
Pt  presented to Clinic 2 days after vaccine administration @ his PCP office. He states that day 1 post vaccine he woke somewhat disoriented with flu-like symptoms, stumbled when attempting to put on pants & leaned on a wall with left deltoid . Injection site (left deltoid) was extremely painful) . He took advil x 1 with significant improvement ; Noticed last night  (day 1 post vaccine) that he had a 6 cmx6 cm redness surrounding injection site.
no energy at all; aches and pains; fever over 105 for like 5 days; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days). At the time of the report, ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter No treatment  Medications were  provided by Reporter   Reporter did not allow further contact
Information has been received from an 82 year old male patient with "codeine allergy" and a history of knee operation who "2 year ago" was vaccinated with a dose of ZOSTAVAX (Merck) (SC, 0.65ml).  Concomitant therapy was reported as valacyclovir HC1 and acetaminophen/oxycodone hydrochloride and doxepin.  It was reported that the patient had pain under his ribs from his chest all the way to his back bone, and went to the emergency room on 06-AUG-2010, an EKG and a chest x-ray were performed and the results were good, so he was told that he had a strain muscle at the hospital.  Two days later, the same pain was there so he went back and from a rash pronounced with the Shingles at hospital on 08-AUG-2010.  On the 16th of August he was given some medicine that did not any good.  The medicine was Gabapentin (manufacturer unspecified).  On 01-SEP-2010, the patient went to see a dermatologist who prescribed him doxepin and valacyclovir HC1 (manufacturers unspecified).  The patient went to see a nurse practitioner on 02-SEP-2010, who game me a shot (name and manufacturer unspecified).  The patient had not recovered at time of report.  Follow up information has been received regarding an 82 year old male patient who "approximately 2 years ago" was vaccinated with a dose of ZOSTAVAX (Merck).  On 08-JUL-2010 (previously reported as 06-AUG-2010) he began experiencing severe pains in chest and spinal areas and went to ER and was diagnosed with a torn ligament.  Pt reported pain continued to be excruciating.  Pt reported that as a nurse was attempting to administer an EKG, the nurse noticed a rash on back area and rib.  ER doctor confirmed case of shingles (previously reported 08-AUG-2010).  The patient was given pain pills and advised to consult family doctor.  Family doctor confirmed diagnosis and gave Rx for gabapentin 100mg tid.  Pain did not subside.  The patient saw a dermatologist and was given oxycodone/APAP and a topical ointment 45gm prudoxine 5%.  Pain continued and it was recommended to consult Pain Management Clinic in hopes to block nerve endings.  Follow-up information has been received from a physician concerning a retired patient with unknown history of chicken pox, and no recent exposure to chicken pox or herpes zoster, who on 26-OCT-2007 (also reported as 26-AUG-2007) was vaccinated into his right arm with his first dose of ZOSTAVAX (Merck) (Lot # 658084/0888U).  The physician stated that on 06-AUG-2010 (previously reported on 08-AUG-2010) the patient developed herpes zoster into his right chest wall ( 8/10 with significant post herpetic neuralgia).  There was not a direct fluorescent antibody, no specimen was collected for PCR and no photos was taken of the lesion.  At the time of report, the patient had not recovered from the herpes zoster with significant post herpetic neuralgia.  Herpes Zoster with significant post herpetic neuralgia was considered to be disabling.  No further information is available.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 10-NOV-2022, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221: US-009507513-2305USA004262:
Pain in the arm; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were received as follows: This case was received via chat. The age group adult selected as per vaccine specification.  The patient received the second dose of Shingrix and was experiencing pain in the arm. The reporter did not consented to follow up.  The patient declined to share any details on the experience.
Runny nose, cough, elevated temperature 99.2-99.9 all occurred on dates 05/11/2017 and 05/12/2017. On 05/13/2017 PM she had runny nose, cough, 101.5 temperature, and spotted rash all over her body. Mainly on torso. Started on forehead and worked its way down her body. She was very irritable and inconsolable. No appetite. Irregular bowel movements. Lethargy. 5/14/2017 AM &PM elevated temp 99.3-99.8, runny nose reddish/pink speckled rash on body. Irritable, cough, lethargy. 5/15/2017 elevated temp 99.4 . Runny nose. Light pink speckled rash. Slightly fussy, mainly content. Tired. Called on call dr at  hospital and she suggested roseola, and said to keep my child home on 5/13/2017 PM. Called pediatricians office to inform them of the situation on 5/15/2014 AM and nurse suggested reaction from vaccine. And said to stay home until rash clears. *all temps taken on forehead.
1 day post vaccine, 3inx3in raised circle hive noted to right upper arm with pain and itching.  increased in size over night to at least 4x4 inches..... on 1/6 early am which is 8 days past vaccination, Arm started itching again and hive noted to be about 1x1 with increasing size and itching.
Patient was given first one on May 19th 2016 and we gave another MENVEO on May 16 2017 because most vaccines were abstracted into the chart the day she got the MENVEO so we thought that if we gave the MENVEO she would be up to date on her vaccines, then on May 19th 2017 all her records were scanned in. The reason we are just catching the error is because she came back in for a vaccine update and pulled her old records, and found that not all old vaccines were abstracted into her chart.
20 expired booster doses(exp date 4 nov 2021) on 5NOV2021; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED on 5NOV2021 in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045C21A) for COVID-19 vaccination.   No Medical History information was reported.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED on 5NOV2021. On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED on 5NOV2021 had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medications were not reported.  Most recent FOLLOW-UP information incorporated above includes on 08-Nov-2021 the follow up received contains non significant information, added patient demographics.
Horrible diarrhea and upset stomach with smelly bowel movements and painful gas to start. Then I started running a 101 degree fever for about 28 hours after that. I continue to have a sharp pain in my left side which feels like gas as I continue to pass really smelly gas.  FYI?I received the Moderna 2 dose vaccine in the spring with no fever and no GI issues with either dose.